chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pain
Clinical narrative: Feeling Tired; Having Chills; Nausea; Feeling achy; Muscle ache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Feeling Tired), CHILLS (Having Chills), NAUSEA (Nausea), PAIN (Feeling achy) and MYALGIA (Muscle ache) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Feb-2021, the patient experienced FATIGUE (Feeling Tired), CHILLS (Having Chills), NAUSEA (Nausea), PAIN (Feeling achy) and MYALGIA (Muscle ache). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form; NAPROXEN SODIUM (ALEVE) ongoing since an unknown date at a dose of 1 dosage form and DIMENHYDRINATE (DRAMAMINE) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FATIGUE (Feeling Tired), CHILLS (Having Chills), NAUSEA (Nausea), PAIN (Feeling achy) and MYALGIA (Muscle ache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Facial pain, Pruritus
Clinical narrative: Soreness in face; Redness in her face; Itching in her face; This spontaneous case was reported by a consumer and describes the occurrence of FACIAL PAIN (Soreness in face), ERYTHEMA (Redness in her face) and PRURITUS (Itching in her face) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025520A and 013l20a) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure high since 01-Jan-2005, Acid reflux (oesophageal) since 01-Jan-2000, Depression since 01-Jan-2011, Drug allergy (codeine) and Sulfonamide allergy (Sulfa drugs). Concomitant products included CHLORTHALIDONE from 01-Jan-2015 to an unknown date, POTASSIUM CHLORIDE from 01-Jan-2019 to an unknown date and ACETYLSALICYLIC ACID (ASPIRIN 81) from 01-Jan-2005 to an unknown date for Blood pressure, VALSARTAN from 01-Jan-2005 to an unknown date for Blood pressure high, ARMODAFINIL (NUVIGIL) from 01-Jan-2005 to an unknown date for Sleep apnea.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced FACIAL PAIN (Soreness in face), ERYTHEMA (Redness in her face) and PRURITUS (Itching in her face). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at a dose of 50 milligram; STEROIDS for Adverse event, at a dose of UNK dosage form; ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP) for Adverse event, at a dose of 1000 milligram and CYANOCOBALAMIN, FOLIC ACID (VITAMIN B12 & FOLIC ACID) for Adverse event, at a dose of 2000 milligram. On 01-Mar-2021, ERYTHEMA (Redness in her face) and PRURITUS (Itching in her face) had resolved with sequelae. At the time of the report, FACIAL PAIN (Soreness in face) outcome was unknown.            Most recent FOLLOW-UP information incorporated above includes: On 29-Apr-2021: Follow up received on 29 April 2021 added patient demographics, medical history, vaccine information, concomitant medication,event outcome, treatment information.
Sex: M
Vaccine: COVID19
Symptoms: Muscular weakness, Paraesthesia, Tremor
Clinical narrative: Tremor Arm; Tingling Arm; Strong Weakness Left Arm (Injected Arm); This spontaneous case was reported by a consumer and describes the occurrence of TREMOR (Tremor Arm), PARAESTHESIA (Tingling Arm) and MUSCULAR WEAKNESS (Strong Weakness Left Arm (Injected Arm)) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced TREMOR (Tremor Arm), PARAESTHESIA (Tingling Arm) and MUSCULAR WEAKNESS (Strong Weakness Left Arm (Injected Arm)). At the time of the report, TREMOR (Tremor Arm), PARAESTHESIA (Tingling Arm) and MUSCULAR WEAKNESS (Strong Weakness Left Arm (Injected Arm)) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment information provided.
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Vaccination site discolouration
Clinical narrative: red from elbow to shoulder; black/blue at injection site; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red from elbow to shoulder) and VACCINATION SITE DISCOLOURATION (black/blue at injection site) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, the patient experienced ERYTHEMA (red from elbow to shoulder) and VACCINATION SITE DISCOLOURATION (black/blue at injection site). At the time of the report, ERYTHEMA (red from elbow to shoulder) and VACCINATION SITE DISCOLOURATION (black/blue at injection site) outcome was unknown. Not Provided          Concomitant Medications were not provided by the reporter. Treatment Medications were not provided by the reporter.   This case was linked to MOD-2021-028149 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Swelling; Itchy; Redness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history). Concomitant products included ALENDRONATE SODIUM (FOSAMAX) for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness). On 03-Feb-2021, VACCINATION SITE SWELLING (Swelling), VACCINATION SITE PRURITUS (Itchy) and VACCINATION SITE ERYTHEMA (Redness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Pain
Clinical narrative: Patient started feeling stinging and burning feeling in her body immediately after the vaccination; Patient started feeling stinging and burning feeling in her body immediately after the vaccination; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Patient started feeling stinging and burning feeling in her body immediately after the vaccination) and BURNING SENSATION (Patient started feeling stinging and burning feeling in her body immediately after the vaccination) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, the patient experienced PAIN (Patient started feeling stinging and burning feeling in her body immediately after the vaccination) and BURNING SENSATION (Patient started feeling stinging and burning feeling in her body immediately after the vaccination). At the time of the report, PAIN (Patient started feeling stinging and burning feeling in her body immediately after the vaccination) and BURNING SENSATION (Patient started feeling stinging and burning feeling in her body immediately after the vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided.
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Vaccination site pain
Clinical narrative: Loss of sensation to the left side of her face, specifically her left jaw and front left side of her tongue; Soreness in her arm; This spontaneous case was reported by a nurse and describes the occurrence of HYPOAESTHESIA (Loss of sensation to the left side of her face, specifically her left jaw and front left side of her tongue) and VACCINATION SITE PAIN (Soreness in her arm) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 17-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jan-2021, the patient experienced HYPOAESTHESIA (Loss of sensation to the left side of her face, specifically her left jaw and front left side of her tongue) and VACCINATION SITE PAIN (Soreness in her arm). On 18-Jan-2021, HYPOAESTHESIA (Loss of sensation to the left side of her face, specifically her left jaw and front left side of her tongue) had resolved. At the time of the report, VACCINATION SITE PAIN (Soreness in her arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Ibuprofen
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose decreased, Dizziness, Lid sulcus deepened
Clinical narrative: she had low blood sugar; droppy eyes; dizziness was extreme; she could not get up; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE DECREASED (she had low blood sugar), LID SULCUS DEEPENED (droppy eyes) and DIZZINESS (dizziness was extreme; she could not get up) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced BLOOD GLUCOSE DECREASED (she had low blood sugar), LID SULCUS DEEPENED (droppy eyes) and DIZZINESS (dizziness was extreme; she could not get up). At the time of the report, BLOOD GLUCOSE DECREASED (she had low blood sugar), LID SULCUS DEEPENED (droppy eyes) and DIZZINESS (dizziness was extreme; she could not get up) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment reported.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: COVID-19 virus test positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus test positive) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, COVID-19: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: A sore arm a few days after vaccine and arm is still sore; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (A sore arm a few days after vaccine and arm is still sore) in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced PAIN IN EXTREMITY (A sore arm a few days after vaccine and arm is still sore). At the time of the report, PAIN IN EXTREMITY (A sore arm a few days after vaccine and arm is still sore) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Pain in extremity
Clinical narrative: fatigue; headache; both sides of hips started hurting; arm started huting with internal pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm started huting with internal pain), FATIGUE (fatigue), HEADACHE (headache) and ARTHRALGIA (both sides of hips started hurting) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M204) for COVID-19 vaccination.     Concomitant products included OLMESARTAN, ROSUVASTATIN, ESTRADIOL, CENTRUM SILVER [ASCORBIC ACID;BIOTIN;BORON;CALCIUM;CALCIUM PANTOTHENATE;CHLORINE;CHROMIUM;COLECALCIFEROL;COPPER;CYANOCOBALAMIN;FOLIC ACID;IODINE;MAGNESIUM;MANGANESE;MOLYBDENUM;NICKEL;NICOTINAMIDE;PHOSPHORUS;PHYTOMENADIONE;POTASSIUM;PYRIDOXINE HYDROCH, CALCIUM and VITAMIN D3 for an unknown indication.    On 17-Feb-2021 at 10:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-Feb-2021 at 11:00 AM, the patient experienced PAIN IN EXTREMITY (arm started huting with internal pain) and ARTHRALGIA (both sides of hips started hurting). On 25-Feb-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (arm started huting with internal pain) had not resolved, FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown and ARTHRALGIA (both sides of hips started hurting) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication use was not provided by reporter.    Most recent FOLLOW-UP information incorporated above includes: On 02-Jul-2021: Follow-up information received on 02-JULY-2021 contains No New information.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Feeling hot, Injection site warmth, Pain, Peripheral swelling
Clinical narrative: It is very hard under that spot; Skin feels prickly.; Started to have minor itching at the injection site; It is very red; Arm started to get swollen again; Feel warm; Today it feels worse; Arm feels like Its on fire if I touch on it; size of the palm of my hand.; Swollen arm; Little sore; Little warm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore), FEELING HOT (Little warm), PERIPHERAL SWELLING (Arm started to get swollen again) and INJECTION SITE WARMTH (Feel warm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore) and FEELING HOT (Little warm). On 25-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm started to get swollen again), INJECTION SITE WARMTH (Feel warm), CONDITION AGGRAVATED (Today it feels worse), VACCINATION COMPLICATION (Arm feels like Its on fire if I touch on it), PRURITUS (size of the palm of my hand.), RASH (Skin feels prickly.), VACCINATION SITE PRURITUS (Started to have minor itching at the injection site) and VACCINATION SITE ERYTHEMA (It is very red). On an unknown date, the patient experienced VACCINATION SITE INDURATION (It is very hard under that spot). At the time of the report, PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore), FEELING HOT (Little warm), PERIPHERAL SWELLING (Arm started to get swollen again), INJECTION SITE WARMTH (Feel warm), CONDITION AGGRAVATED (Today it feels worse), VACCINATION COMPLICATION (Arm feels like Its on fire if I touch on it), PRURITUS (size of the palm of my hand.), VACCINATION SITE INDURATION (It is very hard under that spot), RASH (Skin feels prickly.), VACCINATION SITE PRURITUS (Started to have minor itching at the injection site) and VACCINATION SITE ERYTHEMA (It is very red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.  Patient mentioned that she got the root canal done on 24feb2021 and they gave 3-4 injection of Lidocaine in that area and Nitrous oxide.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Nonsignificant Followup Appended-NNI On 03-May-2021: Non Significant Follow up-NNI
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Vaccination complication, Vaccination site erythema, Vaccination site induration
Clinical narrative: It is very hard under that spot; Skin feels prickly.; Started to have minor itching at the injection site; It is very red; Arm started to get swollen again; Feel warm; Today it feels worse; Arm feels like Its on fire if I touch on it; size of the palm of my hand.; Swollen arm; Little sore; Little warm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore), FEELING HOT (Little warm), PERIPHERAL SWELLING (Arm started to get swollen again) and INJECTION SITE WARMTH (Feel warm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore) and FEELING HOT (Little warm). On 25-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm started to get swollen again), INJECTION SITE WARMTH (Feel warm), CONDITION AGGRAVATED (Today it feels worse), VACCINATION COMPLICATION (Arm feels like Its on fire if I touch on it), PRURITUS (size of the palm of my hand.), RASH (Skin feels prickly.), VACCINATION SITE PRURITUS (Started to have minor itching at the injection site) and VACCINATION SITE ERYTHEMA (It is very red). On an unknown date, the patient experienced VACCINATION SITE INDURATION (It is very hard under that spot). At the time of the report, PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore), FEELING HOT (Little warm), PERIPHERAL SWELLING (Arm started to get swollen again), INJECTION SITE WARMTH (Feel warm), CONDITION AGGRAVATED (Today it feels worse), VACCINATION COMPLICATION (Arm feels like Its on fire if I touch on it), PRURITUS (size of the palm of my hand.), VACCINATION SITE INDURATION (It is very hard under that spot), RASH (Skin feels prickly.), VACCINATION SITE PRURITUS (Started to have minor itching at the injection site) and VACCINATION SITE ERYTHEMA (It is very red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.  Patient mentioned that she got the root canal done on 24feb2021 and they gave 3-4 injection of Lidocaine in that area and Nitrous oxide.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Nonsignificant Followup Appended-NNI On 03-May-2021: Non Significant Follow up-NNI
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: It is very hard under that spot; Skin feels prickly.; Started to have minor itching at the injection site; It is very red; Arm started to get swollen again; Feel warm; Today it feels worse; Arm feels like Its on fire if I touch on it; size of the palm of my hand.; Swollen arm; Little sore; Little warm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore), FEELING HOT (Little warm), PERIPHERAL SWELLING (Arm started to get swollen again) and INJECTION SITE WARMTH (Feel warm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore) and FEELING HOT (Little warm). On 25-Feb-2021, the patient experienced PERIPHERAL SWELLING (Arm started to get swollen again), INJECTION SITE WARMTH (Feel warm), CONDITION AGGRAVATED (Today it feels worse), VACCINATION COMPLICATION (Arm feels like Its on fire if I touch on it), PRURITUS (size of the palm of my hand.), RASH (Skin feels prickly.), VACCINATION SITE PRURITUS (Started to have minor itching at the injection site) and VACCINATION SITE ERYTHEMA (It is very red). On an unknown date, the patient experienced VACCINATION SITE INDURATION (It is very hard under that spot). At the time of the report, PERIPHERAL SWELLING (Swollen arm), PAIN (Little sore), FEELING HOT (Little warm), PERIPHERAL SWELLING (Arm started to get swollen again), INJECTION SITE WARMTH (Feel warm), CONDITION AGGRAVATED (Today it feels worse), VACCINATION COMPLICATION (Arm feels like Its on fire if I touch on it), PRURITUS (size of the palm of my hand.), VACCINATION SITE INDURATION (It is very hard under that spot), RASH (Skin feels prickly.), VACCINATION SITE PRURITUS (Started to have minor itching at the injection site) and VACCINATION SITE ERYTHEMA (It is very red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.  No concomitant medication was provided.  Patient mentioned that she got the root canal done on 24feb2021 and they gave 3-4 injection of Lidocaine in that area and Nitrous oxide.   Most recent FOLLOW-UP information incorporated above includes: On 03-May-2021: Nonsignificant Followup Appended-NNI On 03-May-2021: Non Significant Follow up-NNI
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal congestion
Clinical narrative: Nasal congestion; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NASAL CONGESTION (Nasal congestion) in a 58-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Feb-2021, the patient experienced NASAL CONGESTION (Nasal congestion). At the time of the report, NASAL CONGESTION (Nasal congestion) had not resolved.            Treatment information included antibiotics and nasal spray.  No concomitant medication was provided.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pain in extremity
Clinical narrative: Arm pain; All over body pain; Tirred; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm pain), PAIN (All over body pain) and FATIGUE (Tirred) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Arm pain), PAIN (All over body pain) and FATIGUE (Tirred). At the time of the report, PAIN IN EXTREMITY (Arm pain), PAIN (All over body pain) and FATIGUE (Tirred) had not resolved.            Treatment medication was not provided. Action taken with mRNA-1273 in response to the event was not applicable
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity
Clinical narrative: Arm redness; Feels likes someone has punched me in the arm; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Arm redness) and PAIN IN EXTREMITY (Feels likes someone has punched me in the arm) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced ERYTHEMA (Arm redness) and PAIN IN EXTREMITY (Feels likes someone has punched me in the arm). At the time of the report, ERYTHEMA (Arm redness) and PAIN IN EXTREMITY (Feels likes someone has punched me in the arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.  The patient reported that it felt warm when the vaccine went in.
Age: 41.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Pyrexia, Vaccination site pain
Clinical narrative: Diarrhea; Tiredness; Low grade fever; Slight pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), FATIGUE (Tiredness), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (Slight pain at injection site) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (esophageal).   On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced DIARRHOEA (Diarrhea), FATIGUE (Tiredness), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (Slight pain at injection site). The patient was treated with BISMUTH SUBSALICYLATE (PEPTO-BISMOL) for Diarrhea, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DIARRHOEA (Diarrhea) had not resolved and FATIGUE (Tiredness), PYREXIA (Low grade fever) and VACCINATION SITE PAIN (Slight pain at injection site) outcome was unknown.            Concomitant product use included medications for acid reflux.   Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) in a 35-year-old female patient (gravida 3, para 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012A21A and 004M20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine NOS, Anxiety and Endometriosis. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]), SERTRALINE HYDROCHLORIDE (ZOLOFT) and DOXYLAMINE SUCCINATE, PYRIDOXINE HYDROCHLORIDE (BONJESTA) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 24-Oct-2020 and the estimated date of delivery was 30-Jul-2021. On 27-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirteenth week of the pregnancy.  On 27-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Nov-2021, Pregnancy test: positive (Positive) Positive.         Patient was reported to have 2 live full-term births previously with pregnancy end dates on 29-AUG-2015 and 21-FEB-2017 respectively. For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments. Internal review conducted on 22jul2021 resulted in updates to pregnancy information
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Peripheral swelling, Pruritus
Clinical narrative: extreme itchiness on the inner portion of arm from elbow to wrist; extreme redness on the inner portion of arm from elbow to wrist; burning on both hands; itchiness on both hands; top of left hand slightly swollen; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (extreme itchiness on the inner portion of arm from elbow to wrist), ERYTHEMA (extreme redness on the inner portion of arm from elbow to wrist), FEELING HOT (burning on both hands), PRURITUS (itchiness on both hands) and PERIPHERAL SWELLING (top of left hand slightly swollen) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced PRURITUS (extreme itchiness on the inner portion of arm from elbow to wrist), ERYTHEMA (extreme redness on the inner portion of arm from elbow to wrist), FEELING HOT (burning on both hands), PRURITUS (itchiness on both hands) and PERIPHERAL SWELLING (top of left hand slightly swollen). At the time of the report, PRURITUS (extreme itchiness on the inner portion of arm from elbow to wrist), ERYTHEMA (extreme redness on the inner portion of arm from elbow to wrist), FEELING HOT (burning on both hands), PRURITUS (itchiness on both hands) and PERIPHERAL SWELLING (top of left hand slightly swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Blood glucose, Confusional state, Decreased appetite, Diarrhoea
Clinical narrative: Diarrhea; Lack of appetite; Aches in legs muscle; Confusion; Feels shaking when he stands; Weak; Couldn't control urine; Lethargic; Fell from bed to floor bc he was so weak; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), TREMOR (Feels shaking when he stands), ASTHENIA (Weak), URINARY INCONTINENCE (Couldn't control urine) and LETHARGY (Lethargic) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced CONFUSIONAL STATE (Confusion), TREMOR (Feels shaking when he stands), ASTHENIA (Weak), URINARY INCONTINENCE (Couldn't control urine), LETHARGY (Lethargic), ASTHENIA (Fell from bed to floor bc he was so weak), DECREASED APPETITE (Lack of appetite) and MYALGIA (Aches in legs muscle). On 26-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Diarrhea, at an unspecified dose and frequency and INULIN for Blood glucose, at an unspecified dose and frequency. On 25-Feb-2021, CONFUSIONAL STATE (Confusion) and ASTHENIA (Fell from bed to floor bc he was so weak) had resolved. On 26-Feb-2021, URINARY INCONTINENCE (Couldn't control urine) had resolved. At the time of the report, TREMOR (Feels shaking when he stands), ASTHENIA (Weak), DIARRHOEA (Diarrhea), DECREASED APPETITE (Lack of appetite) and MYALGIA (Aches in legs muscle) had not resolved and LETHARGY (Lethargic) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Blood glucose: 217-278 (High) blood sugar was 217 -278 (took a day)..         Concomitant medications were not reported.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Lethargy, Myalgia, Tremor, Urinary incontinence
Clinical narrative: Diarrhea; Lack of appetite; Aches in legs muscle; Confusion; Feels shaking when he stands; Weak; Couldn't control urine; Lethargic; Fell from bed to floor bc he was so weak; This spontaneous case was reported by a consumer and describes the occurrence of CONFUSIONAL STATE (Confusion), TREMOR (Feels shaking when he stands), ASTHENIA (Weak), URINARY INCONTINENCE (Couldn't control urine) and LETHARGY (Lethargic) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 030L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Diabetes mellitus.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced CONFUSIONAL STATE (Confusion), TREMOR (Feels shaking when he stands), ASTHENIA (Weak), URINARY INCONTINENCE (Couldn't control urine), LETHARGY (Lethargic), ASTHENIA (Fell from bed to floor bc he was so weak), DECREASED APPETITE (Lack of appetite) and MYALGIA (Aches in legs muscle). On 26-Feb-2021, the patient experienced DIARRHOEA (Diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Diarrhea, at an unspecified dose and frequency and INULIN for Blood glucose, at an unspecified dose and frequency. On 25-Feb-2021, CONFUSIONAL STATE (Confusion) and ASTHENIA (Fell from bed to floor bc he was so weak) had resolved. On 26-Feb-2021, URINARY INCONTINENCE (Couldn't control urine) had resolved. At the time of the report, TREMOR (Feels shaking when he stands), ASTHENIA (Weak), DIARRHOEA (Diarrhea), DECREASED APPETITE (Lack of appetite) and MYALGIA (Aches in legs muscle) had not resolved and LETHARGY (Lethargic) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Feb-2021, Blood glucose: 217-278 (High) blood sugar was 217 -278 (took a day)..         Concomitant medications were not reported.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Lip swelling, Rash
Clinical narrative: Lips are little bit swollen; I am having rash on back of the body and on arms; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RASH (I am having rash on back of the body and on arms) and LIP SWELLING (Lips are little bit swollen) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 25-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced RASH (I am having rash on back of the body and on arms) and LIP SWELLING (Lips are little bit swollen). At the time of the report, RASH (I am having rash on back of the body and on arms) and LIP SWELLING (Lips are little bit swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not applicable.
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Hypoacusis, Pain, Pyrexia
Clinical narrative: Possible hearing impairing following vaccination; Fever (104); Tired; Aches and pains; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 26-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Aches and pains), HYPOACUSIS (Possible hearing impairing following vaccination), PYREXIA (Fever (104)) and FATIGUE (Tired) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 012M20A) for COVID-19 vaccination.     Concomitant products included CALCIUM CARBONATE, CHONDROITIN SULFATE, GLUCOSAMINE HYDROCHLORIDE (GLUCOSAMINE CHONDROITIN CALCIUM) and FISH OIL for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PAIN (Aches and pains), PYREXIA (Fever (104)) and FATIGUE (Tired). On an unknown date, the patient experienced HYPOACUSIS (Possible hearing impairing following vaccination). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN (Aches and pains), HYPOACUSIS (Possible hearing impairing following vaccination), PYREXIA (Fever (104)) and FATIGUE (Tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 24-Feb-2021, Body temperature: 104 (High) fever (104).         Treatment also included Topical steroid.   This case was linked to MOD-2021-061273 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Follow up received: Reporter information updated, New event  was added.
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: First dose about three weeks ago; A spontaneous report  was received from a consumer, concerning a male patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and the patient stated that he had received his first dose about three weeks ago without any side effects.  The patient's medical history was not provided. No concomitant product use was provided.  The patient received their first of two planned doses of mRNA-1273 (Batch number: Unknown) about three weeks ago without any side effects. On 25 Feb 2021, the patient received their second of two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection.  On an unknown date, it was reported that the patient received his first dose about three weeks ago without any side effects.  Treatment information was not provided.  The patient received both scheduled doses of mRNA-1273 prior to the events; therefore, action taken with the drug in response to the event is not applicable.  The outcome of the event, Inappropriate schedule of vaccine administered was considered unknown.  Upon internal review on 13 Apr 2021, action taken with mRNA-1273 in response to the event was updated.; Reporter's Comments: This report refers to a case of Inappropriate schedule of vaccine administered for mRNA-1273, lot # unknown  with no associated AEs.; Sender's Comments: Kindly reassess the start date of first dose.
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Decreased appetite, Fatigue, Headache, Nausea, Rash
Clinical narrative: loss appetite; fatigue; rash (L) arm; headache; nausea; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea), VACCINATION SITE PAIN (pain at injection site), DECREASED APPETITE (loss appetite) and FATIGUE (fatigue) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced HEADACHE (headache), NAUSEA (nausea) and VACCINATION SITE PAIN (pain at injection site). On 05-Feb-2021, the patient experienced DECREASED APPETITE (loss appetite), FATIGUE (fatigue) and RASH (rash (L) arm). On 08-Jan-2021, HEADACHE (headache) and NAUSEA (nausea) had resolved. On 10-Jan-2021, VACCINATION SITE PAIN (pain at injection site) had resolved. On 06-Feb-2021, DECREASED APPETITE (loss appetite) and FATIGUE (fatigue) had resolved. At the time of the report, RASH (rash (L) arm) outcome was unknown. Not Provided          No concomitant medications reported. Treatment included Baby Aspirin
Age: 78.0
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: loss appetite; fatigue; rash (L) arm; headache; nausea; pain at injection site; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache), NAUSEA (nausea), VACCINATION SITE PAIN (pain at injection site), DECREASED APPETITE (loss appetite) and FATIGUE (fatigue) in a 78-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011L20A and 004M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 08-Jan-2021, the patient experienced HEADACHE (headache), NAUSEA (nausea) and VACCINATION SITE PAIN (pain at injection site). On 05-Feb-2021, the patient experienced DECREASED APPETITE (loss appetite), FATIGUE (fatigue) and RASH (rash (L) arm). On 08-Jan-2021, HEADACHE (headache) and NAUSEA (nausea) had resolved. On 10-Jan-2021, VACCINATION SITE PAIN (pain at injection site) had resolved. On 06-Feb-2021, DECREASED APPETITE (loss appetite) and FATIGUE (fatigue) had resolved. At the time of the report, RASH (rash (L) arm) outcome was unknown. Not Provided          No concomitant medications reported. Treatment included Baby Aspirin
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Oral pain, Pyrexia
Clinical narrative: Mouth is sore on left side; Fever of 101.2; This spontaneous case was reported by a consumer and describes the occurrence of ORAL PAIN (Mouth is sore on left side) and PYREXIA (Fever of 101.2) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025a21a) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced ORAL PAIN (Mouth is sore on left side) and PYREXIA (Fever of 101.2). At the time of the report, ORAL PAIN (Mouth is sore on left side) and PYREXIA (Fever of 101.2) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: Pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) in a 34-year-old female patient (gravida 2) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 04-Mar-2021. On 24-Feb-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy). On 24-Feb-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by reporter.  Patient was 38 1/2 weeks pregnant.